Welcome to our dedicated page for Raytech Holding SEC filings (Ticker: RAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Raytech Holding's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Raytech Holding's regulatory disclosures and financial reporting.
Raytech Holding Limited is a British Virgin Islands holding company listed on Nasdaq, with all operations conducted through Hong Kong subsidiaries and reporting in Hong Kong dollars. As of March 31, 2026 it had 2,724,911 Ordinary Shares outstanding, rising to 5,874,743 shares as of a later date.
The group is expanding from sourcing and wholesaling personal care electrical appliances into personal health care electronics and service lines such as product design, project advisory and marketing solutions. This shift, plus the December 2025 acquisition of Worry free Group (Hong Kong) Limited for US$6,099,000 (US$4,099,000 cash and a US$2,000,000 promissory note at 2% interest), drove accounts receivable up to HKD67,775,993 (US$8,644,897) and resulted in negative operating cash flow of HKD14,511,287 (US$1,850,928) for fiscal 2026, partly funded by a June 2026 registered direct offering raising about US$6.08 million.
Raytech highlights heavy dependence on a small customer base, including one customer contributing 62.5% of fiscal 2026 revenue, and on a related-party manufacturer in mainland China that supplied 62.1% of purchases. Management discloses material weaknesses in internal control over financial reporting, significant political and regulatory risks tied to Hong Kong and potential PRC oversight, concentration of ownership in two 17.01% shareholders, and future dilution from a 2024 equity incentive plan authorizing up to 2,500,000 shares.
FORTUNE GENESIS HOLDINGS LIMITED reports beneficial ownership of 999,014 Ordinary Shares of Raytech Holding Limited, representing 17.01% of the outstanding Ordinary Shares. These shares carry both sole voting power and sole dispositive power, with no shared voting or dispositive power.
The 17.01% ownership is calculated against 5,874,743 Ordinary Shares outstanding, derived from 2,724,911 shares outstanding prior to a public offering plus 3,149,832 shares sold in a public offering that closed on June 29, 2026. The disclosure is signed by director YUAN Tianfu on behalf of Fortune Genesis Holdings Limited.
Raytech Holding Limited has a significant shareholder disclosed in a Schedule 13G filing. WK FRATER HOLDINGS LIMITED reports beneficial ownership of 999,014 Ordinary Shares of Raytech Holding Limited, each with a par value of US$0.0001 per share.
This position represents 17.01% of Raytech’s Ordinary Shares outstanding. The reporting person holds sole voting power and sole dispositive power over all 999,014 shares, with no shared voting or dispositive power.
The 17.01% ownership is calculated using a total of 5,874,743 Ordinary Shares outstanding, derived from 2,724,911 shares outstanding prior to an offering and 3,149,832 shares sold in a public offering that closed on June 29, 2026.
Hash Digital Investment Limited reports beneficial ownership of 165,836 ordinary shares of Raytech Holding Limited, representing 6.09% of the class. The filing states the percentage is calculated from 2,724,911 Ordinary Shares outstanding as of the Issuer's Prospectus on Form 424B5 dated June 22, 2026. The Schedule 13G shows sole voting and dispositive power over the 165,836 shares. The filing is signed by Wang Yuhua, Director on July 6, 2026.
Raytech Holding Limited completed a registered direct offering of 3,149,832 ordinary shares at US$1.97 per share, raising approximately US$6.2 million in gross proceeds. The shares were issued under its effective Form F-3 shelf registration statement and a June 18, 2026 prospectus supplement.
The company will use net proceeds for general corporate and working capital purposes, to support expansion into personal health care electronics, and to fund integration and post-closing working capital needs for its acquisition of Worry Free Group (Hong Kong) Limited. Affiliates Fortune Genesis Holdings Limited and WK Frater Holdings Limited each bought 999,014 shares on the same terms and agreed to a lock-up through September 20, 2026.
Raytech Holding Limited offers 3,149,832 Ordinary Shares at US$1.97 per share in a primary placement under a prospectus supplement. The offering prices total gross proceeds of US$6,217,768 and net proceeds are estimated at US$6,084,660. The prospectus states total Ordinary Shares outstanding before this offering as 2,724,911 and immediately after this offering as 5,874,743. Two purchasers—Fortune Genesis Holdings Limited and WK Frater Holdings Limited—are affiliated with certain directors and large shareholders and will each purchase 999,014 Ordinary Shares at the public offering price; the company relies on the foreign private issuer home country practice exemption instead of Nasdaq shareholder approval. Net proceeds are earmarked for general corporate and working capital purposes, expansion into personal health care electronics and integration/post-closing costs related to the Worry free Group acquisition.
Raytech Holding Ltd director Liu Haoyuan filed an initial statement of beneficial ownership on Form 3. The filing identifies Liu as a director of Raytech but, in the data provided, does not show any reported purchases, sales, or other insider transactions in company securities.
Raytech Holding Limited is shifting its strategy toward services for personal health care electronics, including product design, development, and consultation, led by subsidiary Raytech Innovation Limited. The legacy personal care electrical appliances trading business via Pure Beauty Manufacturing will continue, while Worry Free Group remains the Group’s independent marketing solutions arm.
To support this pivot, Raytech has appointed Mr. Haoyuan Liu as Chairman and Executive Director, effective April 15, 2026, adding fintech, capital markets, and regulatory experience to the leadership team alongside Executive Director Mr. Ching Tim Hoi. The company reported cash and cash equivalents of HK$121.5 million (US$15.6 million) as of September 30, 2025, which it highlights as providing capacity to execute the new strategy. Management is targeting the fast‑growing Asia Pacific wearable medical devices segment, cited at US$12.55 billion in 2025 and projected to reach US$26.83 billion by 2030, and views the new services platform as its main growth engine.
Raytech Holding Limited appointed Mr. Haoyuan Liu as a director and as Chairman of the Board, effective immediately. Former Chairman Mr. Tim Hoi Ching will remain on the Board, and the change is stated not to result from any disagreement over operations, policies, or practices.
Mr. Liu will receive annual cash compensation of $6,000, payable quarterly, under an offer letter, and is party to an indemnity agreement. His background spans fintech operations, family office and hedge fund roles, and capital markets across Hong Kong, Singapore, and the United States. This report is incorporated by reference into Raytech’s effective Form F-3 registration statement.
Raytech Holding Ltd director Li Shihua has filed an initial insider ownership report on Form 3. The filing identifies Li Shihua as a director and shows no reportable stock purchases, sales, option exercises, gifts, or other transactions in the transaction summary data.